Four Influential Clinical Trials in Human Papilloma Virus-Associated Oropharynx Cancer
- PMID: 32171456
- DOI: 10.1016/j.ijrobp.2019.12.015
Four Influential Clinical Trials in Human Papilloma Virus-Associated Oropharynx Cancer
Comment on
- 
  
  Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell Carcinoma.J Clin Oncol. 2019 Aug 1;37(22):1909-1918. doi: 10.1200/JCO.19.00463. Epub 2019 Jun 4. J Clin Oncol. 2019. PMID: 31163012 Free PMC article. Clinical Trial.
- 
  
  Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.J Clin Oncol. 2019 Oct 10;37(29):2661-2669. doi: 10.1200/JCO.19.01007. Epub 2019 Aug 14. J Clin Oncol. 2019. PMID: 31411949 Free PMC article. Clinical Trial.
- 
  
  A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx.Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):725-732. doi: 10.1016/j.ijrobp.2019.11.021. Epub 2019 Nov 27. Int J Radiat Oncol Biol Phys. 2020. PMID: 31785337 Clinical Trial.
- 
  
  Correction to Lancet Oncol 2019; 20: 1349-59.Lancet Oncol. 2019 Dec;20(12):e663. doi: 10.1016/S1470-2045(19)30725-9. Lancet Oncol. 2019. PMID: 31797789 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
- Medical
 
        